Clinical Trial Update: Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study [NA]

View source ↗

Summary

A randomized trial evaluating circulating DNA to improve outcomes in oncology is currently recruiting for colorectal cancer and non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut Bergonié | Conditions: Colorectal Cancer, Non Small Cell Lung Cancer | NA | Status: RECRUITING